Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

542 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study.
Sano T, Amano K, Ide T, Isoda H, Honma Y, Morita Y, Yano Y, Nakamura H, Itano S, Miyajima I, Shirachi M, Kuwahara R, Ohno M, Kawaguchi T, Tsutsumi T, Nakano D, Arinaga-Hino T, Kawaguchi M, Eguchi Y, Torimura T, Takahashi H, Harada M, Kawaguchi T; SAKS Study Group. Sano T, et al. Among authors: isoda h. Hepatol Res. 2024 Apr;54(4):326-335. doi: 10.1111/hepr.13993. Epub 2023 Nov 28. Hepatol Res. 2024. PMID: 37975277
A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis.
Sano T, Amano K, Ide T, Yokoyama K, Noguchi K, Nakamura H, Isoda H, Ohno M, Shirachi M, Morita Y, Yano Y, Sumie S, Kawaguchi T, Kuwahara R, Arinaga-Hino T, Takahashi H, Shakado S, Hirai F, Kawaguchi T. Sano T, et al. Among authors: isoda h. Hepatol Res. 2023 Jan;53(1):26-34. doi: 10.1111/hepr.13837. Epub 2022 Sep 20. Hepatol Res. 2023. PMID: 36066400
Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Yamamura S, Nakano D, Hashida R, Tsutsumi T, Kawaguchi T, Okada M, Isoda H, Takahashi H, Matsuse H, Eguchi Y, Sumida Y, Nakajima A, Gerber L, Younossi ZM, Torimura T. Yamamura S, et al. Among authors: isoda h. J Gastroenterol Hepatol. 2021 Mar;36(3):629-636. doi: 10.1111/jgh.15172. Epub 2020 Jul 16. J Gastroenterol Hepatol. 2021. PMID: 32627871 Review.
Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
Inadomi C, Takahashi H, Ogawa Y, Oeda S, Imajo K, Kubotsu Y, Tanaka K, Kessoku T, Okada M, Isoda H, Akiyama T, Fukushima H, Yoneda M, Anzai K, Aishima S, Nakajima A, Eguchi Y. Inadomi C, et al. Among authors: isoda h. Hepatol Res. 2020 Jun;50(6):682-692. doi: 10.1111/hepr.13495. Epub 2020 Mar 25. Hepatol Res. 2020. PMID: 32090397
Regional Program to Reduce Liver Cancer Associated With Viral Hepatitis B: Comprehensive Approach Corroborating With the Media and Regional Government to Improve Population Screening Rate in Saga Prefecture.
Eguchi Y, Isoda H, Takahashi H. Eguchi Y, et al. Among authors: isoda h. Clin Liver Dis (Hoboken). 2021 May 1;17(4):309-311. doi: 10.1002/cld.1037. eCollection 2021 Apr. Clin Liver Dis (Hoboken). 2021. PMID: 33968394 Free PMC article. Review. No abstract available.
Infection phase is a predictor of pruritus in patients with hepatitis B virus infection.
Oeda S, Takahashi H, Isoda H, Komukai S, Imajo K, Yoneda M, Ono M, Hyogo H, Kawaguchi T, Fujii H, Kawanaka M, Sumida Y, Tanaka S, Kawamoto H, Torimura T, Saibara T, Kawaguchi A, Nakajima A, Eguchi Y. Oeda S, et al. Among authors: isoda h. Biomed Rep. 2019 Aug;11(2):63-69. doi: 10.3892/br.2019.1224. Epub 2019 Jun 21. Biomed Rep. 2019. PMID: 31338192 Free PMC article.
542 results